Tissue inhibitor of metalloproteinase-3 induces apoptosis in prostate cancer cells and confers increased sensitivity to paclitaxel

European Journal of Cancer

Volumn 42, Issue 18, 2006, Pages 3267-3273

  Deng, Xiyun ^a,b   Bhagat, Sunita ^a   Dong, Zhong ^a   Mullins, Chadwick ^a   Chinni, Sreenivasa Rao ^a   Cher, Michael ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central South University   (China)

Author keywords

Adenovirus; Apoptosis; Chemosensitivity; Gene therapy; Paclitaxel; Prostate cancer; Tissue inhibitor of metalloproteinase

Indexed keywords

CASPASE 3; PACLITAXEL; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOSTASIS; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SUICIDE GENE THERAPY; VIRAL GENE THERAPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CASPASES; DRUG SYNERGISM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIA; NEOPLASM PROTEINS; PACLITAXEL; PROSTATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED;

EID: 33845210681     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.07.003     Document Type: Article

References (39)

1. Jemal A., Murray T., Ward E., et al. CA Cancer J Clin 55 (2005) 10-30
2. Gopalkrishnan R.V., Kang D.C., and Fisher P.B. J Cell Physiol 189 (2001) 245-256
3. Kuyu H., Lee W.R., Bare R., Hall M.C., and Torti F.M. Ann Oncol 10 (1999) 891-898
4. Kantoff P.W., Halabi S., Conaway M., et al. J Clin Oncol 17 (1999) 2506-2513
5. Tannock I.F., Osoba D., Stockler M.R., et al. J Clin Oncol 14 (1996) 1756-1764
6. Bhandari M.S., Petrylak D.P., and Hussain M. Eur J Cancer 41 (2005) 941-953
7. Heidenreich A., von Knobloch R., and Hofmann R. Eur Urol 39 (2001) 121-130
8. McCaffrey J.A., Hilton S., Mazumdar M., et al. J Clin Oncol 15 (1997) 2449-2455
9. Kaye S.B., Piccart M., Aapro M., Francis P., and Kavanagh J. Eur J Cancer 33 (1997) 2167-2170
10. Strother J.M., Beer T.M., and Dreicer R. Eur J Cancer 41 (2005) 954-964
11. Bokemeyer C., Hartmann J.T., Kuczyk M.A., et al. World J Urol 16 (1998) 155-162
12. Kitamura T., Nishimatsu H., Hamamoto T., Tomita K., Takeuchi T., and Ohta T. Expert Rev Anticancer Ther 2 (2002) 59-71
13. Odrazka K., Vanasek J., Vaculikova M., Stejskal J., and Filip S. Neoplasma 47 (2000) 197-203
14. Gilligan T., and Kantoff P.W. Urology 60 (2002) 94-100
15. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Eur J Cell Biol 74 (1997) 111-122
16. Baker A.H., Zaltsman A.B., George S.J., and Newby A.C. J Clin Invest 101 (1998) 1478-1487
17. Baker A.H., George S.J., Zaltsman A.B., Murphy G., and Newby A.C. Br J Cancer 79 (1999) 1347-1355
18. Smith M.R., Kung H., Durum S.K., Colburn N.H., and Sun Y. Cytokine 9 (1997) 770-780
19. Bian J., Wang Y., Smith M.R., et al. Carcinogenesis 17 (1996) 1805-1811
20. Ahonen M., Ala-Aho R., Baker A.H., et al. Mol Ther 5 (2002) 705-715
21. Andreu T., Beckers T., Thoenes E., Hilgard P., and von Melchner H. J Biol Chem 273 (1998) 13848-13854
22. Bachman K.E., Herman J., Corn G., et al. Cancer Res 59 (1999) 798-802
23. Loging W.T., and Reisman D. Oncogene 18 (1999) 7608-7615
24. Pennie W.D., Hegamyer G.A., Young M.R., and Colburn N.H. Cell Growth Differ 10 (1999) 279-286
25. Ueki T., Toyota M., Sohn T., et al. Cancer Res 60 (2000) 1835-1839
26. Span P.N., Lindberg R.L., Manders P., et al. J Pathol 202 (2004) 395-402
27. Wetzel M., Rosenberg G.A., and Cunningham L.A. Eur J Neurosci 18 (2003) 1050-1060
28. Kaighn M.E., Narayan K.S., Ohnuki Y., Lechner J.F., and Jones L.W. Invest Urol 17 (1979) 16-23
29. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., and Paulson D.F. Int J Cancer 21 (1978) 274-281
30. Deng X., Kim M., Vandier D., et al. Biochem Biophys Res Commun 296 (2002) 792-798
31. Chinni S.R., and Sarkar F.H. Clin Cancer Res 8 (2002) 1228-1236
32. Apte S.S., Olsen B.R., and Murphy G. J Biol Chem 270 (1995) 14313-14318
33. Philpott N.J., Turner A.J., Scopes J., et al. Blood 87 (1996) 2244-2251
34. Cory S., and Adams J.M. Nat Rev Cancer 2 (2002) 647-656
35. Igney F.H., and Krammer P.H. Nat Rev Cancer 2 (2002) 277-288
36. Ahonen M., Poukkula M., Baker, et al. Oncogene 22 (2003) 2121-2134
37. Scaffidi C., Fulda S., Srinivasan A., et al. EMBO J 17 (1998) 1675-1687
38. Bond M., Murphy G., Bennett M.R., Newby A.C., and Baker A.H. J Biol Chem 277 (2002) 13787-13795
39. Karbowski M., and Youle R.J. Cell Death Differ 10 (2003) 870-880